372
Views
1
CrossRef citations to date
0
Altmetric
Short Communication

Synthesis and biological evaluation of novel 6, 7-dimethoxy-3-(4-pyridyl)-2,3,3a,4-tetrahydroindeno[1,2-c]pyrazol-2-yl-4-substituted phenylmethanone/ethanone derivatives

, , , , , , , , , & show all
Pages 155-159 | Received 12 Jan 2011, Accepted 12 Apr 2011, Published online: 03 Jun 2011

References

  • Robert JN, Yu-Jin J. Immunity to tuberculosis. Annu Rev Immunol 2004;22:599–623.
  • Kazionny B, Wells CD, Kluge H, Gusseynova N, Molotilov V. Implications of the growing HIV-1 epidemic for tuberculosis control in Russia. Lancet 2001;358:1513–1514.
  • Morozova I, Riekstina V, Sture G, Wells C, Leimane V. Impact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia. Int J Tuberc Lung Dis 2003;7:903–906.
  • Sbarbaro JA. ‘Multidrug’-resistant tuberculosis. It is time to focus on the private sector of medicine. Chest 1997;111:1149–1151.
  • Fujiwara PI, Cook SV, Rutherford CM, Crawford JT, Glickman SE, Kreiswirth BN et al. A continuing survey of drug-resistant tuberculosis, New York City, April 1994. Arch Intern Med 1997;157:531–536.
  • Schaberg T, Gloger G, Reichert B, Mauch H, Lode H. Resistant lung tuberculosis in Berlin 1987–1993. Pneumologie 1996;50:21–27.
  • Blair IA, Mansilla Tinoco R, Brodie MJ, Clare RA, Dollery CT, Timbrell JA et al. Plasma hydrazine concentrations in man after isoniazid and hydralazine administration. Hum Toxicol 1985;4:195–202.
  • Ali MA, Shaharyar M, Siddiqui AA. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives. Eur J Med Chem 2007;42:268–275.
  • Ali MA, Yar MS, Hasan MZ, Ahsan MJ, Pandian S. Design, synthesis and evaluation of novel 5,6-dimethoxy-1-oxo-2,3-dihydro-1H-2-indenyl-3,4-substituted phenyl methanone analogues. Bioorg Med Chem Lett 2009;19:5075–5077.
  • Ali MA, Samy JG, Manogaran E, Sellappan V, Hasan MZ, Ahsan MJ et al. Synthesis and antimycobacterial evaluation of novel 5,6-dimethoxy-1-oxo-2,5-dihydro-1H-2-indenyl-5,4-substituted phenyl methanone analogues. Bioorg Med Chem Lett 2009;19:7000–7002.
  • Küçükgüzel SG, Rollas S. Synthesis, characterization of novel coupling products and 4-arylhydrazono-2-pyrazoline-5-ones as potential antimycobacterial agents. Farmaco 2002;57:583–587.
  • Ali MA, Shaharyar M. Oxadiazole mannich bases: Synthesis and antimycobacterial activity. Bioorg Med Chem Lett 2007;17:3314–3316.
  • Shaharyar M, Ali MA, Bakht MA, Murugan V. Synthesis and antimycobacterial activity of 4-[5-(substituted phenyl)-4, 5-dihydro-3-isoxazolyl]-2-methylphenols. J Enzyme Inhib Med Chem 2008;23:432–436.
  • Ragavan RV, Vijayakumar V, Kumari NS. Synthesis and antimicrobial activities of novel 1,5-diaryl pyrazoles. Eur J Med Chem 2010;45:1173–1180.
  • Heifets LB, Flory MA, Lindholm-Levy PJ. Does pyrazinoic acid as an active moiety of pyrazinamide have specific activity against mycobacterium tuberculosis? Antimicrob Agents Chemother 1989;33:1252–1254.
  • Gundersen LL, Nissen-Meyer J, Spilsberg B. Synthesis and antimycobacterial activity of 6-arylpurines: The requirements for the N-9 substituent in active antimycobacterial purines. J Med Chem 2002;45:1383–1386.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.